GCT is at #CTAD2023! The event is taking place in Boston, 24-27 Oct, and it provides an opportunity to bring together key industry professionals and Key Opinion Leaders (KOLs) in Alzheimer’s disease to discuss the latest innovations and effective treatment development.

With over 20 years of experience in CNS and Psychiatry and numerous clinical trials conducted in Alzheimer’s Disease, GCT’s knowledge will be a valuable asset in supporting Pharma and Biotech companies focused on this neurodegenerative disease.